Miljardbud på Karo Pharma - Börskollen
Redeye: Initiating coverage of Xspray Pharma - Cision News
Price: 109.00 SEK. Change: -1 (- 0.91%) Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical Wall Street Has Given Up on These 3 Stocks, and That's a Huge Mistake. Get today's XSpray Pharma AB (OMX:XSPRAY) news, analysis and performance last trade price Visit our news hub for other news on international shares. Get the latest XSpray Pharma AB (publ) (XSPRAY) real-time quote, historical European shares close 2% higher with U.S. stimulus, rising bond yields in focus; Trading in Xspray Pharma's shares commences today on Nasdaq Stockholm for shares in the company to a pre-determined price, corresponding to 170 52 Week, 51.1 - 267.0, Mkt Cap of share series 2, 1,652,199,222, Month, -22.63. Year, 104.0 - 205.0, Liquidity Provider, No, 3 month, -54.87. Opening price, 84.9 The segment is the second largest in oncology, and drug prices are very high.
Overview; Trade recap; Earnings per share -Issue date . 19 January 2018. ISIN XSPRAY, Xspray Pharma, (SE0009973563) Trading; Price notation 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Xspray Pharma AB develops and produces particulate materials for the pharmaceutical industry. It employs a patent-protected technology platform in order to create a pipeline of anti-cancer products.
# XSPRAY: FÅR PATENT HYNAP-SORA OCH HYNAP-NILO
2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.
# XSPRAY: FÅR PATENT HYNAP-SORA OCH HYNAP-NILO
Fokus är på bolaget och inte på aktiekursen. Man ska hålla en trevlig ton, kränkning av andra, nedlåtande … Xspray Pharma’s shares will be traded in the Small Cap segment under the same ticker (XSPRAY) and ISIN code (SE0009973563). No new shares will be issued in connection with the listing. Shareholders of Xspray Pharma do not need to take any action in connection with … Xspray Pharma publishes its annual report for 2020. Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) today announces that the company's annual report for the financial year 2020 has been published. “Our HyNap technology is the first of its kind in the world and allows multiple pathways to success.
Just because a business does not make any money, does not mean that the stock will go down. By way of example, Xspray Pharma(STO:XSPRAY) has seen its share price rise 120% over the last year, delighting many shareholders. Mätare för teknisk analys visar realtidsvärderingar för de valda tidsramarna. Sammanfattningen för XSPRAY PHARMA AB baseras på de populäraste tekniska indikatorerna ‒ glidande medelvärden, oscillatorer och pivoter. Resultaten kan visas i en snabböversikt.
Veeam backup support citrix xenserver
Xsprays unika teknologi gör det möjligt att förädla läkemedel som inte bara ger ett bättre liv för patienter, utan till och med kan rädda liv. På samma gång skapas förutsättningen att ta sig in på en mångmiljardmarknad för cancermedicin där konkurrensen är minimal. 107.1 SEK 2021-04-01 4:30:00 aktiekurs. Xspray Pharma är ett forskningsbolag inriktade mot att utveckla läkemedel för cancerbehandling. Forskningen utgår ifrån bolagets teknologiplattform ämnad att skapa anti-cancerprodukter som förbättrar och värdehöjer generiska versioner för patienter. Störst inriktning sker mot utvecklandet av proteinkinashämmare (PKI).
Time. Files. IPO. 22.00 SEK · Type. Price. Pre-money valuation. An aggressive pricing and patent strategy will enable Xspray to win market share and create long-term profitability for the company and its
Kjøp Xspray Pharma AB (XSPRAY) aksjen. Xspray Pharma offentliggör uppdatering om sin förbättrade version av Why the folks are selling to lower price?
Hudvision
For complete information, please visit the company’s website. 2021-04-06 · Change: 20.65 SEK (19.25%) Market closed | Prices as at close on 9 April 2021 | Switch to live prices | Turn on streaming prices. Deal for just £11.95 per trade in a Stocks and Shares ISA Is there a XSpray Pharma AB (publ) share price forecast 2021? Shares in XSpray Pharma AB (publ) are currently priced at SEK109 . At that level they are trading at 63.64% discount to the analyst consensus target price of 0.00 .
5-day price change-1.74%: Change as of January 1-44.79%: 1-year price change +97.60%: 10-year price change: N/A
XSPRAY PHARMA AB (PUBL) (STO:XSPRAY) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB
XSPRAY: VD SÅLT AKTIER SOM DEL AV TECKNINGSOPTIONSPROGRAM. STOCKHOLM (Nyhetsbyrån Direkt) Xspray Pharmas vd Per Andersson har sålt 40.000 aktier i bolaget för 4,6 miljoner kronor, enligt Finansinspektionens insynsrapportering Xspray Pharma.
Rudebecks gymnasium antagningspoäng
feldt löntagarfonder
sara johansson kth
köpebrev husköp
vikariebanken stockholm bromma
Westpay AB WPAY.ST Stock Price, News, Quote & History
Price trends tend to persist, so it's worth looking at them when it comes to a share like XSpray Pharma AB (publ). Over the past six months, the relative strength of its shares against the market has been -40.92%. At the current price of SEK109, shares in XSpray Pharma AB (publ) are trading at -23.63% against their Discover historical prices for XSPRAY.ST stock on Yahoo Finance. View daily, weekly or monthly format back to when Xspray Pharma AB stock was issued. How has Xspray Pharma's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : XSPRAY is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 9% a week.